| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013433 Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus |
| 01/11/2000 | US6013278 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/11/2000 | US6013267 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
| 01/11/2000 | US6013266 Live attenuated bacteria of the species Actinobacillus pleuropneumoniae |
| 01/11/2000 | US6013265 For immunization against and preventing clinical symptoms associated with herpes simplex virus infections |
| 01/11/2000 | US6013264 Comprising hepatitis b surface antigen (hbsag); stability, efficiency; for immunization against diphtheria, tetanus, pertussis, polio, haemophilus influenzae b, hepatitis a, meningitis a, meningitis b, meningitis c, and otitis media |
| 01/11/2000 | US6013263 As inhibitory of human and non-human retroviral, especially human immunodeficiency viurs (hiv), transmission to uninfected cells |
| 01/11/2000 | US6013262 Recombinant papilloma virus L1 |
| 01/11/2000 | US6013261 For immunization |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013251 Antiviral against human immuno deficiency virus (hiv), cytomegalovirus, herpes simplex virus (hsv) |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/11/2000 | CA2195027C Hiv protease inhibitors useful for the treatment of aids |
| 01/11/2000 | CA2150832C Antibiotic formulation and use for bacterial infections |
| 01/07/2000 | CA2276791A1 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 01/06/2000 | WO2000000634A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 01/06/2000 | WO2000000618A2 Polyketides and their synthesis |
| 01/06/2000 | WO2000000615A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000501A1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 01/06/2000 | WO2000000500A2 Polyketides and their synthesis |
| 01/06/2000 | WO2000000479A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 01/06/2000 | WO2000000475A1 Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 01/06/2000 | WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 01/06/2000 | WO2000000216A2 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | WO2000000214A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | WO1999058505A3 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 01/06/2000 | WO1999055900A3 Gcp |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | CA2336285A1 Aryl phosphate derivatives of d4t having anti-hiv activity |
| 01/06/2000 | CA2335523A1 Polyketides and their synthesis |
| 01/06/2000 | CA2335508A1 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2333643A1 Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 01/06/2000 | CA2332127A1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | CA2331845A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2000 | CA2330110A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 01/05/2000 | EP0969017A1 Modified C1-esterase inhibitor for blocking infectivity of HIV |
| 01/05/2000 | EP0969013A1 Peptides for inhibiting HPV E7 proteins |
| 01/05/2000 | EP0968722A1 Improved modified live BRSV vaccine |
| 01/05/2000 | EP0968721A2 Use of a composition comprising a peptide for the inhibition of HIV |
| 01/05/2000 | EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments |
| 01/05/2000 | EP0968477A1 Coincidence detection method, products and apparatus |
| 01/05/2000 | EP0968297A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
| 01/05/2000 | EP0968293A1 Staphylococcus 3-dehydroquinate synthase |
| 01/05/2000 | EP0968276A1 NOVEL clpL |
| 01/05/2000 | EP0968225A1 NOVEL spsB |
| 01/05/2000 | EP0968222A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 01/05/2000 | EP0968214A1 Purification process |
| 01/05/2000 | EP0968199A1 Antibacterial heterocyclic amino acid derivatives |
| 01/05/2000 | EP0967991A1 Infectious bursitis vaccine |
| 01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 01/05/2000 | EP0967974A1 Spermicide |
| 01/05/2000 | EP0967878A1 Targeted cytotoxic cells |
| 01/05/2000 | EP0800512B1 Antiherpes peptidomimetic compounds |
| 01/05/2000 | EP0689381B1 Mucosal competitive exclusion flora |
| 01/05/2000 | EP0652758B1 Diphtheria toxin vaccines |
| 01/05/2000 | EP0641357B1 Hiv protein epitopes immunologically homologous to hla |
| 01/05/2000 | DE19829014A1 Modifizierter C1-Esterase-Inhibitor zur Blockierung der Infektiosität von HIV Modified C1-esterase inhibitor to block the infectivity of HIV |
| 01/05/2000 | DE19818842C1 Cold remedy containing sugar alcohol mixture such as Isomalt, having immunostimulant and antimicrobial activity |
| 01/05/2000 | CN1240360A In oVO vaccination against newcastle disease |
| 01/05/2000 | CN1240357A Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6010901 Vectors |
| 01/04/2000 | US6010895 Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat |
| 01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010848 Screening methods using an atpase protein from hepatitis C virus |
| 01/04/2000 | US6010718 Extended release formulations of erythromycin derivatives |
| 01/04/2000 | US6010705 Attenuated, invasive vaccines against fish pathogens |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | US6010703 Genetic engineering; inserting gene into gene encoding thymidine kinase |
| 01/04/2000 | US6010700 Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | CA2029537C Pradimicin derivatives |
| 12/30/1999 | CA2276564A1 Modified c1 esterase inhibitor for blocking the infectiousness of hiv |
| 12/29/1999 | WO1999067417A2 Fitness assay and associated methods |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067388A1 Antisense oligonucleotide inhibiting the expression of il-10 protein |
| 12/29/1999 | WO1999067294A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 12/29/1999 | WO1999067286A2 Novel staphylococcus peptides for bacterial interference |
| 12/29/1999 | WO1999067285A1 Particles of hcv envelope proteins: use for vaccination |
| 12/29/1999 | WO1999067272A1 A compound, wf002, production thereof and use thereof |
| 12/29/1999 | WO1999067258A1 Arylsulfonanilide phosphates |
| 12/29/1999 | WO1999067255A1 Propenyl cephalosporin derivatives |
| 12/29/1999 | WO1999067254A2 Multi-drug resistant retroviral protease inhibitors and use thereof |
| 12/29/1999 | WO1999067242A1 Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials |
| 12/29/1999 | WO1999067241A1 (heterocyclic) methyl substituted carbapenem antibacterials |
| 12/29/1999 | WO1999067240A1 (heterocyclic)methyl substituted carbapenem antibacterials |
| 12/29/1999 | WO1999067238A2 Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999067210A1 Stable no-delivering compounds |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066956A1 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP) |
| 12/29/1999 | WO1999066954A1 Synthetic peptide vaccines for foot-and-mouth disease |